The worldwide nebulizer market is growing strongly due to technological advancements, rising rates of respiratory illnesses, and an aging population. Market valued at USD 1.11 Bn (2022) and is projected to USD 1.75 Bn by 2029, at a 6.62% of CAGR during forecast. (Maximize Market Research)
Market Size, Growth Factors and Opportunities
The increase in respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis has fueled the growth of respiratory care device market. This increase is attributed to various factors, including growing pollution, a sedentary lifestyle, and greater consumption of tobacco and alcohol. With around 235 million people globally affected by asthma, according to the World Health Organisation, effective treatment options such as nebulisers are urgently needed.
Request Sample Link For More Details:https://www.maximizemarketresearch.com/request-sample/30706/
Abstract: Advances in technology have resulted in smaller and more convenient nebulizers, improving patient adherence to therapy and facilitating market penetration for home healthcare. Additionally, rising elderly population, who are more vulnerable to respiratory illness,is expected to drive the growth of nebulizer market. Also, growing awareness programs by different organizations like Global Initiative for Chronic Obstructive Lung Disease (GOLD), in order to create awareness regarding respiratory diseases & associated treatments will stimulate the market growth.
2024: Trends, Investments & the State of the U.S. Market
The U.S. nebulizer market trends and investment by the companies were observed which would help to develop nebulizers for respiratory care in 2024. Perhaps most importantly, the U.S. Food and Drug Administration (FDA) granted approval for Ohtuvayre (ensifentrine) for treatment of COPD. Administered via a standard jet nebulizer directly into the lungs, Ohtuvayre does not require high inspiratory flow or complicated hand-breath coordination. Meaning, this approval is a major step forward and should help fuel increased use of nebulizer therapies in the U.S. for COPD management.
Market Segmentation and Segments Covered Per this Report
On the basis of type and modality, the nebulizer market is segmented as follows: By type, the mesh nebulizers segment accounted for the largest share of the market in 2022. In comparison with other nebulised pharmaceutical drug delivery devices, these devices are preferred for new developments because of their high portablility, high comfort, short treatment time, low residual volume, and precise targeting to the lungs. This has become one of the major driving factors for the growing adoption of mesh nebulizers, and is expected to further propel its growth with technological advancements in the mesh nebulizers.
In terms of modality, the market was dominated by portable nebulizers in 2022. They are simple to use, battery operated and best for patients who do not require excessive assistance by health care professionals. The demand for portable nebulizers, globally, is projected to increase due to a continuous technological innovations regarding medical devices.
Want to access more insights? The journey starts from requesting Sample : https://www.maximizemarketresearch.com/request-sample/30706/
PESTLE Analysis: Global Market Top 5 Companies
A large number of companies are involved in a business that fuels the global nebuliser market, occupying the major part of the market. Which of these makes it to the top five ranks by market share:
OMRON Healthcare, Inc. — OMRON is one of the largest manufacturers of medical device and introduced OMRON NE C106 in July 2020 which is a nebulizer usable for all age groups. Such strategy plans to better meet a wider range of patient demographics and reinforce OMRON’s position in the marketplace.
Koninklijke Philips N.V. — A leading integrated technology company specialised in developing healthcare solutions through advanced technologies. With the growing need for nebulizer systems, these people have their approach to innovating novel nebulizer systems.
Global LAMIRA Product Launch | PARI Respiratory Equipment, Inc.: PARI Respiratory Equipment, Inc. as a whole has made great advances as of March 2021 when the LAMIRA Nebulizer System was approved in Japan. In this instance, the system is designed to deliver ARIKAYCE, another example of PARI specializing in dedicated aerosol delivery systems.
The company is well-known for its extensive respiratory portfolio, but the nebulizer market offers an opportunity for DeVilbiss to provide solutions that also improve device performance and patient comfort.
Aerogen: A market leader in aerosol drug delivery, Aerogen’s technology is used in hospitals around the globe. The constant investment in the research and development has resulted in many, advanced nebulization technologies.
To Gain More Insights into the Market Analysis, Browse Summary of the Research Report :https://www.maximizemarketresearch.com/market-report/global-nebulizer-market/30706/
By Region UK Germany France Japan China Rest of World
United States: Due to high prevalence of respiratory disease, technological advances in nebulizer and its benefits from reimbursement in the U.S., it accounted for considerable share of worldwide nebulizer market in 2022. These latest developments, including the recent approval of new therapies like Ohtuvayre within the country, exemplify the commitment to further advancement of respiratory care within Canada.
UK: The rise in Respiratory disorders in UK is increasing the demand for nebulizers. The market growth is further driven by government initiatives related to air pollution and healthcare infrastructure.
Germany: The country is home to a strong healthcare system and a focus on innovation in the medical device field, thus making it an important market for nebulizers in Europe. Strong emphasis in research and development across the country helps in bringing new nebuliser technology in the country.
France: The growth of the geriatric population and the rise in incidences of chronic respiratory diseases has propelled the demand for nebulizers in France. Additionally, the market is propelled by government policies promoting home contribution services.
Japan: The increasing cases of respiratory disorders due to the aging population of Japan is driven the nebulizer market in this country. Reimbursement policies and opportunities for innovation from the government in medical devices are supportive.
Conclusion
The program cell examination market is probably going to notice enormous growth attributable to technical progress, increasing prevalence of chronic disorders, and growing drugs discovery and personalised medicine investment. AI, automation, and high-throughput screening technologies are likely to improve speed and accuracy in cell analysis even more, making it an essential tool used in healthcare and research.
Related Reports :
CRISPR And Cas Genes Market https://www.maximizemarketresearch.com/market-report/crispr-and-cas-genes-market/127232/
Analytical Instrumentation Market https://www.maximizemarketresearch.com/market-report/analytical-instrumentation-market/145973/
Global Resuscitation Devices Market https://www.maximizemarketresearch.com/market-report/global-resuscitation-devices-market/79882/
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 9607365656
